Normal view MARC view ISBD view

Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.

Paton, D M

Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. [electronic resource] - Drugs of today (Barcelona, Spain : 1998) Dec 2019 - 727-734 p. digital

Publication Type: Journal Article

ISSN: 1699-3993

Standard No.: 10.1358/dot.2019.55.12.3078389 doi

Subjects--Topical Terms:
Amyloid Neuropathies, Familial--complications
Benzoxazoles--therapeutic use
Cardiomyopathies--complications
Humans
Prealbumin

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)